AR074604A1 - Derivados de 5-amino-2-(1-hidroxi-etil)-tetrahidropirano. - Google Patents
Derivados de 5-amino-2-(1-hidroxi-etil)-tetrahidropirano.Info
- Publication number
- AR074604A1 AR074604A1 ARP090104821A ARP090104821A AR074604A1 AR 074604 A1 AR074604 A1 AR 074604A1 AR P090104821 A ARP090104821 A AR P090104821A AR P090104821 A ARP090104821 A AR P090104821A AR 074604 A1 AR074604 A1 AR 074604A1
- Authority
- AR
- Argentina
- Prior art keywords
- tetrahydropirane
- etil
- hydroxi
- derivatives
- amino
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D497/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D497/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Compuestos antibacterianos de la fórmula (1) en donde R1 representa alcoxi (notablemente metoxi); R2 representa H o F; o cada uno de R3, R4, R5 y R6 representa independientemente H o D; V representa CH y W representa CH o N o V representa N y W representa CH; Y representa CH o N; Z representa O, S o CH2; y A representa CH2, CH2CH2 o CD2CD2 y a sales de tales compuestos. Uso de los mismos para el tratamiento de una infección bacteriana y composiciones farmacéuticas que los contienen como principio activo.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IB2008055261 | 2008-12-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR074604A1 true AR074604A1 (es) | 2011-01-26 |
Family
ID=41723046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP090104821A AR074604A1 (es) | 2008-12-12 | 2009-12-11 | Derivados de 5-amino-2-(1-hidroxi-etil)-tetrahidropirano. |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US8211890B2 (es) |
| EP (1) | EP2376497B1 (es) |
| JP (1) | JP4955835B2 (es) |
| KR (1) | KR101297450B1 (es) |
| CN (1) | CN102232078B (es) |
| AR (1) | AR074604A1 (es) |
| AU (1) | AU2009325902B2 (es) |
| BR (1) | BRPI0924081A2 (es) |
| CA (1) | CA2744456C (es) |
| CL (1) | CL2011001413A1 (es) |
| CY (1) | CY1114869T1 (es) |
| DK (1) | DK2376497T3 (es) |
| ES (1) | ES2435596T3 (es) |
| HR (1) | HRP20140010T1 (es) |
| IL (1) | IL213432A (es) |
| MA (1) | MA32956B1 (es) |
| MX (1) | MX2011005905A (es) |
| MY (1) | MY159183A (es) |
| NZ (1) | NZ593891A (es) |
| PL (1) | PL2376497T3 (es) |
| PT (1) | PT2376497E (es) |
| RU (1) | RU2525541C2 (es) |
| SG (1) | SG172088A1 (es) |
| SI (1) | SI2376497T1 (es) |
| TW (1) | TWI426076B (es) |
| WO (1) | WO2010067332A1 (es) |
| ZA (1) | ZA201105095B (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR076222A1 (es) | 2009-04-09 | 2011-05-26 | Actelion Pharmaceuticals Ltd | Derivados 2-hidroxietil-1h-quinolin-ona y sus analogos azaisotericos con actividad antibacteriana y composiciones farmaceuticas que los contienen |
| ES2578182T3 (es) | 2011-05-31 | 2016-07-21 | Actelion Pharmaceuticals Ltd. | Procedimientos de preparación de intermediarios sintéticos que pueden usarse para la fabricación de antibióticos |
| US20140243302A1 (en) * | 2011-06-27 | 2014-08-28 | Merck Sharp & Dohme Corporation | Bridged bicyclic compounds for the treatment of bacterial infections |
| WO2013038374A1 (en) | 2011-09-16 | 2013-03-21 | Actelion Pharmaceuticals Ltd | Process for manufacturing a synthetic intermediate |
| AR089929A1 (es) | 2012-02-10 | 2014-10-01 | Actelion Pharmaceuticals Ltd | Proceso para manufacturar un derivado de naftiridina |
| AR090844A1 (es) | 2012-04-27 | 2014-12-10 | Actelion Pharmaceuticals Ltd | Proceso para elaborar derivados de naftiridina |
| TW201722965A (zh) * | 2015-08-16 | 2017-07-01 | 葛蘭素史密斯克藍智慧財產發展有限公司 | 用於抗菌應用之化合物 |
| TW201833120A (zh) | 2017-02-17 | 2018-09-16 | 瑞士商愛杜西亞製藥有限公司 | 芳基噁唑啶酮抗生素化合物 |
| MY201438A (en) | 2017-08-09 | 2024-02-22 | Denali Therapeutics Inc | Compounds, compositions and methods |
| PT3676297T (pt) * | 2017-09-01 | 2023-08-29 | Denali Therapeutics Inc | Compostos, composições e métodos |
| MA54959A (fr) | 2019-02-13 | 2021-12-22 | Denali Therapeutics Inc | Composés, compositions et procédés |
| WO2020168011A1 (en) | 2019-02-13 | 2020-08-20 | Denali Therapeutics Inc. | Compounds, compositions and methods |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1095611A1 (ru) * | 1982-09-10 | 2007-06-27 | Краснодарский ордена Трудового Красного Знамени политехнический институт | Хлорид 5-хлорметил-2-этил-8-метил-4Н-м-диоксино-(4,5-с)-пиридиния, обладающий антимикробной активностью |
| ES2188584T3 (es) * | 1991-03-28 | 2003-07-01 | Eisai Co Ltd | Derivados heterociclicos de amina. |
| GB9822450D0 (en) | 1998-10-14 | 1998-12-09 | Smithkline Beecham Plc | Medicaments |
| GB0101577D0 (en) | 2001-01-22 | 2001-03-07 | Smithkline Beecham Plc | Compounds |
| GB0112834D0 (en) | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
| JP4445753B2 (ja) * | 2002-01-29 | 2010-04-07 | グラクソ グループ リミテッド | アミノピペリジン誘導体 |
| AR040336A1 (es) * | 2002-06-26 | 2005-03-30 | Glaxo Group Ltd | Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto |
| TW200427688A (en) | 2002-12-18 | 2004-12-16 | Glaxo Group Ltd | Antibacterial agents |
| DE10316081A1 (de) * | 2003-04-08 | 2004-10-21 | Morphochem AG Aktiengesellschaft für kombinatorische Chemie | Neue Verbindungen mit antibakterieller Aktivität |
| US7160888B2 (en) | 2003-08-22 | 2007-01-09 | Warner Lambert Company Llc | [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia |
| JP2008505920A (ja) | 2004-07-08 | 2008-02-28 | グラクソ グループ リミテッド | 抗菌剤 |
| CA2580621A1 (en) | 2004-09-24 | 2006-03-30 | Actelion Pharmaceuticals Ltd | New bicyclic antibiotics |
| JP5314244B2 (ja) | 2004-10-27 | 2013-10-16 | 富山化学工業株式会社 | 新規な含窒素複素環化合物およびその塩 |
| US20090131444A1 (en) * | 2005-05-24 | 2009-05-21 | Astrazeneca Ab | Aminopiperidine Quinolines and Their Azaisosteric Analogues with Antibacterial Activity |
| WO2007016610A2 (en) * | 2005-08-02 | 2007-02-08 | Glaxo Group Limited | Antibacterial agents |
| DK1954697T3 (da) | 2005-10-21 | 2010-06-14 | Glaxo Group Ltd | Peri-kondenserede tricykliske forbindelser, der er anvendelige som antibakterielle midler |
| WO2007071936A1 (en) | 2005-12-22 | 2007-06-28 | Glaxo Group Limited | Heterocyclic compounds, their preparation and their use as antibacterials |
| DE102005062889A1 (de) | 2005-12-29 | 2007-07-05 | Robert Bosch Gmbh | Elektrische Null-Kraft-Steckvorrichtung |
| WO2007086016A1 (en) | 2006-01-26 | 2007-08-02 | Actelion Pharmaceuticals Ltd | Tetrahydropyrane antibiotics |
| CA2643962A1 (en) * | 2006-03-10 | 2007-09-20 | Actelion Pharmaceuticals Ltd | Antibiotic compounds |
| US7709483B2 (en) | 2006-04-06 | 2010-05-04 | Glaxo Group Limited | Pyrrolo-quinoxalinone derivatives as antibacterials |
| GB0613208D0 (en) | 2006-07-03 | 2006-08-09 | Glaxo Group Ltd | Compounds |
| EP1992628A1 (en) | 2007-05-18 | 2008-11-19 | Glaxo Group Limited | Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones |
| CL2008001003A1 (es) | 2007-04-11 | 2008-10-17 | Actelion Pharmaceuticals Ltd | Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana. |
| ES2370123T3 (es) * | 2007-06-15 | 2011-12-12 | Actelion Pharmaceuticals Ltd. | Derivados de 3-amino-6-(1-aminoetil)-tetrahidropirano. |
| ES2426593T3 (es) | 2007-11-26 | 2013-10-24 | Toyama Chemical Co., Ltd. | Derivado de naftiridina monohidrato y método para producir el mismo |
-
2009
- 2009-12-11 MY MYPI2011002646A patent/MY159183A/en unknown
- 2009-12-11 PL PL09796819T patent/PL2376497T3/pl unknown
- 2009-12-11 US US13/139,179 patent/US8211890B2/en not_active Expired - Fee Related
- 2009-12-11 CN CN200980148242.2A patent/CN102232078B/zh not_active Expired - Fee Related
- 2009-12-11 JP JP2011540318A patent/JP4955835B2/ja not_active Expired - Fee Related
- 2009-12-11 MX MX2011005905A patent/MX2011005905A/es active IP Right Grant
- 2009-12-11 AR ARP090104821A patent/AR074604A1/es not_active Application Discontinuation
- 2009-12-11 KR KR1020117015370A patent/KR101297450B1/ko not_active Expired - Fee Related
- 2009-12-11 CA CA2744456A patent/CA2744456C/en active Active
- 2009-12-11 BR BRPI0924081A patent/BRPI0924081A2/pt active Search and Examination
- 2009-12-11 DK DK09796819.2T patent/DK2376497T3/da active
- 2009-12-11 MA MA34003A patent/MA32956B1/fr unknown
- 2009-12-11 SI SI200930791T patent/SI2376497T1/sl unknown
- 2009-12-11 NZ NZ593891A patent/NZ593891A/xx not_active IP Right Cessation
- 2009-12-11 PT PT97968192T patent/PT2376497E/pt unknown
- 2009-12-11 HR HRP20140010AT patent/HRP20140010T1/hr unknown
- 2009-12-11 TW TW098142582A patent/TWI426076B/zh not_active IP Right Cessation
- 2009-12-11 SG SG2011042611A patent/SG172088A1/en unknown
- 2009-12-11 ES ES09796819T patent/ES2435596T3/es active Active
- 2009-12-11 EP EP09796819.2A patent/EP2376497B1/en active Active
- 2009-12-11 RU RU2011128550/04A patent/RU2525541C2/ru not_active IP Right Cessation
- 2009-12-11 WO PCT/IB2009/055689 patent/WO2010067332A1/en not_active Ceased
- 2009-12-11 AU AU2009325902A patent/AU2009325902B2/en not_active Ceased
-
2011
- 2011-06-09 IL IL213432A patent/IL213432A/en not_active IP Right Cessation
- 2011-06-10 CL CL2011001413A patent/CL2011001413A1/es unknown
- 2011-07-11 ZA ZA2011/05095A patent/ZA201105095B/en unknown
-
2013
- 2013-12-18 CY CY20131101136T patent/CY1114869T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR074604A1 (es) | Derivados de 5-amino-2-(1-hidroxi-etil)-tetrahidropirano. | |
| EA201001013A1 (ru) | Бис(сульфониламино)производные для применения в терапии | |
| UY31481A1 (es) | Nuevos derivados de pirimidina, procesos de preparacion, composiciones farmacéuticas conteniéndolos y aplicaciones | |
| BRPI0921701B8 (pt) | Cefarosporina tendo um grupo catecol, seu uso e composição farmacêutica que a compreende | |
| ECSP10010419A (es) | Derivados heterocíclicos de urea y métodos de uso de los mismos-211 | |
| UY32462A (es) | Derivados de bifenilo novedosos para el tratamiento de infección por virus de hepatitis c 644 | |
| NO20083434L (no) | Benzamid- og heteroarenderivater | |
| UY32158A (es) | Derivados heterociclicos y metodos de uso de los mismos | |
| ECSP099451A (es) | Compuestos de urea policíclicos antibacterianos | |
| UY31468A1 (es) | Derivados bis-(sulfonilamino) en terapia 065 | |
| UY31940A (es) | Derivados sustituido del 4,5-(sustituido-piridin-3-il)-1-metil-1h-indol, sus sales farmacéuticamente aceptables, polimorfos, rotámeros, pro-fármacos, anantiómeros, hidratos, solvatos del mismo, composiciones conteniéndolos y aplicaciones | |
| UY30316A1 (es) | Derivados sustituidos de benzamidas, nicotinamidas, propanamidas, acetamidas y carboxamidas n-(2-(piperidin-1-ilmetil)ciclohexil)sustituidas, procesos de preparacion, composiciones conteniéndolos y aplicaciones | |
| CO6270331A2 (es) | Derivados de 1,2,3-triazol para uso como inhibidores de estearoil -coenzima a desaturada | |
| UY32315A (es) | Compuestos de piperidina y usos de los mismo-596 | |
| UY31141A1 (es) | Compuestos de piperidina y sus usos | |
| UY30544A1 (es) | Compuestos de pirrolo-piperidina y sales farmacéuticametne aceptables de los mismos, procesos de fabricacion, composiciones y aplicaciones | |
| CR11825A (es) | Derivados de urea heterociclicos para el tratamiento de infecciones bacterianas | |
| ECSP10010659A (es) | Derivados heterocíclicos de la urea y sus métodos de empleo | |
| AR053554A1 (es) | Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos | |
| UY32674A (es) | Derivados heterociclicos de la urea y sus metodos de empleo | |
| UY32856A (es) | Derivados heterocíclicos de urea y métodos de uso de los mismos | |
| AR064488A1 (es) | DERIVADOS DE4-(1-AMINO-ETIL)-CICLOHEXILAMINA, UNA COMPOSICION FARMACEUTICA QUE LO CONTIENE Y EL USO DE LOS MISMOS PARA LA PREPARACION DE UN MEDICAMENTO PARA EL TRATAMIENTO O PREVENCIoN DE UNA INFECCION BACTERIANA | |
| UY32316A (es) | Derivados de piperidina utiles en el tratamiento de infecciones bacterianas | |
| UY30788A1 (es) | Compuestos quimicos | |
| UY32247A (es) | Nuevos compuestos de aminociclohexilo, composiciones farmacéuticas de los mismos y aplicaciones |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |